Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway
Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway have?
Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway has 60 citations in the OpenAlex counts ScholarIQ stores.
When was Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway published?
Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway has 2021 year in the ScholarIQ index.
What is the open-access status of Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway?
Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway has closed oa status in the ScholarIQ index.
What is the DOI of Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway?
The DOI for Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway is on the source record.
What is the PMID of Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway?
The PMID for Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway is on the source record.
What is the OpenAlex record for Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway?
The OpenAlex for Orcinol glucoside improves the depressive‐like behaviors of perimenopausal depression mice through modulating activity of hypothalamic–pituitary–adrenal/ovary axis and activating <scp>BDNF</scp>‐ <scp>TrkB‐CREB</scp> signaling pathway is on the source record.